カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2012/01/12 | 26,800 | 26,800 | 25,570 | 25,610 | -480 | -1.8% | 236 |
2012/01/11 | 26,990 | 27,280 | 26,070 | 26,090 | -120 | -0.5% | 372 |
2012/01/10 | 27,000 | 27,000 | 26,030 | 26,210 | -1,190 | -4.3% | 697 |
2012/01/06 | 27,500 | 27,700 | 26,900 | 27,400 | -370 | -1.3% | 775 |
2012/01/05 | 28,050 | 28,580 | 27,140 | 27,770 | -560 | -2% | 961 |
2012/01/04 | 28,620 | 29,360 | 27,850 | 28,330 | -1,620 | -5.4% | 2,207 |
2011/12/30 | 34,750 | 34,750 | 29,750 | 29,950 | -4,800 | -13.8% | 5,931 |
2011/12/29 | 34,750 | 34,750 | 34,700 | 34,750 | +5,000 | +16.8% | 1,712 |
2011/12/28 | 27,200 | 29,750 | 27,200 | 29,750 | +5,000 | +20.2% | 3,821 |
2011/12/27 | 24,400 | 24,750 | 23,300 | 24,750 | +90 | +0.4% | 99 |
2011/12/26 | 25,000 | 25,000 | 24,310 | 24,660 | -1,040 | -4% | 148 |
2011/12/22 | 25,300 | 25,700 | 25,210 | 25,700 | +350 | +1.4% | 88 |
2011/12/21 | 25,500 | 25,990 | 25,340 | 25,350 | -740 | -2.8% | 51 |
2011/12/20 | 25,500 | 26,100 | 25,340 | 26,090 | -310 | -1.2% | 49 |
2011/12/19 | 26,500 | 26,700 | 25,400 | 26,400 | -80 | -0.3% | 43 |
2011/12/16 | 26,950 | 26,960 | 25,300 | 26,480 | -520 | -1.9% | 137 |
2011/12/15 | 27,000 | 27,000 | 25,000 | 27,000 | -300 | -1.1% | 88 |
2011/12/14 | 26,700 | 27,300 | 26,400 | 27,300 | +200 | +0.7% | 37 |
2011/12/13 | 27,350 | 27,350 | 26,500 | 27,100 | -390 | -1.4% | 64 |
2011/12/12 | 26,300 | 27,500 | 26,300 | 27,490 | +1,490 | +5.7% | 34 |
2011/12/09 | 25,670 | 26,000 | 25,610 | 26,000 | +10 | ±0% | 12 |
2011/12/08 | 25,610 | 26,200 | 25,510 | 25,990 | -10 | ±0% | 21 |
2011/12/07 | 25,790 | 26,000 | 25,610 | 26,000 | ±0 | ±0% | 49 |
2011/12/06 | 26,900 | 26,900 | 26,000 | 26,000 | -900 | -3.3% | 56 |
2011/12/05 | 25,300 | 26,900 | 25,200 | 26,900 | +1,600 | +6.3% | 98 |
2011/12/02 | 25,010 | 25,300 | 25,000 | 25,300 | +250 | +1% | 87 |
2011/12/01 | 25,100 | 26,000 | 25,000 | 25,050 | +50 | +0.2% | 104 |
2011/11/30 | 24,960 | 25,400 | 24,800 | 25,000 | -100 | -0.4% | 58 |
2011/11/29 | 25,100 | 25,880 | 24,820 | 25,100 | -480 | -1.9% | 83 |
2011/11/28 | 26,000 | 26,000 | 25,100 | 25,580 | +580 | +2.3% | 114 |
2011/11/25 | 24,110 | 25,200 | 24,110 | 25,000 | +500 | +2% | 31 |
2011/11/24 | 24,830 | 25,100 | 24,000 | 24,500 | -800 | -3.2% | 79 |
2011/11/22 | 25,150 | 25,490 | 25,000 | 25,300 | -500 | -1.9% | 103 |
2011/11/21 | 26,300 | 26,300 | 25,200 | 25,800 | -600 | -2.3% | 76 |
2011/11/18 | 25,630 | 26,400 | 25,300 | 26,400 | +300 | +1.1% | 51 |
2011/11/17 | 25,800 | 26,650 | 25,790 | 26,100 | -190 | -0.7% | 36 |
2011/11/16 | 26,150 | 27,500 | 25,800 | 26,290 | -280 | -1.1% | 121 |
2011/11/15 | 26,200 | 27,000 | 26,000 | 26,570 | -30 | -0.1% | 108 |
2011/11/14 | 30,400 | 30,400 | 26,600 | 26,600 | +1,200 | +4.7% | 909 |
2011/11/11 | 25,030 | 25,900 | 25,000 | 25,400 | -300 | -1.2% | 25 |
2011/11/10 | 25,500 | 25,700 | 24,800 | 25,700 | -790 | -3% | 60 |
2011/11/09 | 26,400 | 26,900 | 26,000 | 26,490 | +90 | +0.3% | 66 |
2011/11/08 | 27,290 | 27,750 | 25,700 | 26,400 | -890 | -3.3% | 58 |
2011/11/07 | 27,300 | 27,500 | 26,800 | 27,290 | -610 | -2.2% | 103 |
2011/11/04 | 28,000 | 28,000 | 27,600 | 27,900 | -200 | -0.7% | 41 |
2011/11/02 | 28,200 | 28,300 | 27,700 | 28,100 | -330 | -1.2% | 83 |
2011/11/01 | 28,250 | 28,700 | 28,100 | 28,430 | -70 | -0.2% | 54 |
2011/10/31 | 28,200 | 28,690 | 28,010 | 28,500 | +250 | +0.9% | 29 |
2011/10/28 | 28,100 | 28,920 | 28,010 | 28,250 | -540 | -1.9% | 76 |
2011/10/27 | 29,000 | 29,000 | 27,600 | 28,790 | -210 | -0.7% | 99 |
3151~
3200
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
VIS | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
市場注目の銘柄
チャート関連のコラム